Fig. 1From: Targeting ERBB2 mutations in solid tumors: biological and clinical implicationsLandscape of ERBB2 mutations in cancer. a Proportion of histological subtypes included in the study. b ERBB2 hotspot mutations. c Proportion of patients with ERBB2 mutations according to the histological subtype. d Proportion of patients with activating ERBB2 mutations according to the histological subtypeBack to article page